Amidst a backdrop of mixed performances in European markets, with the STOXX Europe 600 Index ending slightly lower due to global growth concerns, investors continue to explore diverse opportunities. Penny stocks, often representing smaller or newer companies, remain an intriguing area for those seeking affordability combined with growth potential. Despite being considered a somewhat outdated term, these stocks can offer compelling prospects when supported by strong financials and strategic positioning.
Top 10 Penny Stocks In Europe
| Name | Share Price | Market Cap | Rewards & Risks |
| Ariston Holding (BIT:ARIS) | €4.208 | €1.46B | ✅ 5 ⚠️ 2 View Analysis > |
| Maps (BIT:MAPS) | €3.37 | €44.76M | ✅ 4 ⚠️ 2 View Analysis > |
| Angler Gaming (NGM:ANGL) | SEK3.60 | SEK269.95M | ✅ 4 ⚠️ 2 View Analysis > |
| Angler Gaming (DB:0QM) | €0.37 | €247.45M | ✅ 2 ⚠️ 2 View Analysis > |
| Cellularline (BIT:CELL) | €3.12 | €65.81M | ✅ 4 ⚠️ 2 View Analysis > |
| Euroland Société anonyme (ENXTPA:ALERO) | €3.04 | €9.65M | ✅ 2 ⚠️ 5 View Analysis > |
| ForFarmers (ENXTAM:FFARM) | €4.46 | €394.2M | ✅ 4 ⚠️ 1 View Analysis > |
| High (ENXTPA:HCO) | €3.53 | €69.39M | ✅ 1 ⚠️ 4 View Analysis > |
| Deceuninck (ENXTBR:DECB) | €2.095 | €289.57M | ✅ 4 ⚠️ 1 View Analysis > |
| Netgem (ENXTPA:ALNTG) | €0.93 | €31.36M | ✅ 4 ⚠️ 2 View Analysis > |
Click here to see the full list of 328 stocks from our European Penny Stocks screener.
Here's a peek at a few of the choices from the screener.
Invoicery Group (NGM:FRILAN)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Invoicery Group AB, based in Uppsala, Sweden and incorporated in 2014, operates within the invoicing services sector with a market capitalization of SEK141.74 million.
Operations: The company generates revenue from two primary segments: Self-Employment, contributing SEK1.52 billion, and Workforce Management, which accounts for SEK315.64 million.
Market Cap: SEK141.74M
Invoicery Group AB, operating in the invoicing services sector, has demonstrated stable financial management with no long-term liabilities or debt over the past five years. The company's revenue streams are robust, with SEK1.52 billion from Self-Employment and SEK315.64 million from Workforce Management segments. Recent earnings indicate a slight year-on-year increase in revenue for Q2 2025 to SEK474.8 million, although net income decreased to SEK1.63 million from the previous year's SEK3.32 million. Despite these challenges, Invoicery's earnings growth of 33.2% outpaced the industry average decline of 5.5%, highlighting its resilience within the penny stock category.
- Click here to discover the nuances of Invoicery Group with our detailed analytical financial health report.
- Examine Invoicery Group's past performance report to understand how it has performed in prior years.
PCC Exol (WSE:PCX)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: PCC Exol S.A. manufactures and distributes surfactants both in Poland and internationally, with a market cap of PLN459.72 million.
Operations: The company generates revenue primarily from its Specialty Chemicals segment, totaling PLN1.04 billion.
Market Cap: PLN459.72M
PCC Exol S.A. has shown steady financial performance, with recent earnings revealing a sales increase to PLN269.92 million for Q2 2025, up from PLN230.12 million the previous year, and net income rising to PLN9.38 million. The company's Price-To-Earnings ratio of 11.9x is favorable compared to the Polish market average of 13.1x, suggesting potential value for investors in penny stocks. However, challenges remain with high net debt to equity at 58.6% and debt not well covered by operating cash flow at just 7.6%. Despite these concerns, PCC Exol's board is experienced with an average tenure of 10 years.
- Take a closer look at PCC Exol's potential here in our financial health report.
- Assess PCC Exol's previous results with our detailed historical performance reports.
elumeo (XTRA:ELB)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: elumeo SE, with a market cap of €13.75 million, operates through its subsidiaries in the design, procurement, and distribution of gemstone jewelry.
Operations: The company generates revenue primarily from its Jewelry & Watches segment, which amounts to €41.12 million.
Market Cap: €13.75M
elumeo SE, with a market cap of €13.75 million, is grappling with profitability challenges as reflected by its negative return on equity and increasing losses over the past five years. Despite this, the company maintains a solid cash position with short-term assets exceeding both its short and long-term liabilities, providing financial stability. Recent earnings showed a decline in sales to €9.16 million for Q2 2025 compared to the previous year, alongside an increased net loss of €0.647 million. The management team is experienced, and shareholders have not faced significant dilution recently despite restructuring efforts impacting revenue forecasts negatively by up to 15%.
- Click here and access our complete financial health analysis report to understand the dynamics of elumeo.
- Learn about elumeo's future growth trajectory here.
Taking Advantage
- Access the full spectrum of 328 European Penny Stocks by clicking on this link.
- Ready To Venture Into Other Investment Styles? AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if elumeo might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com